Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Department of Hepatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
BMJ Open. 2019 Jul 9;9(7):e028571. doi: 10.1136/bmjopen-2018-028571.
Outcomes in hepatocellular carcinoma (HCC) are determined by both cancer characteristics and liver disease severity. This study aims to validate the use of inpatient electronic health records to determine liver disease severity from treatment and procedure codes.
Retrospective observational study.
Two National Health Service (NHS) cancer centres in England.
339 patients with a new diagnosis of HCC between 2007 and 2016.
Using inpatient electronic health records, we have developed an optimised algorithm to identify cirrhosis and determine liver disease severity in a population with HCC. The diagnostic accuracy of the algorithm was optimised using clinical records from one NHS Trust and it was externally validated using anonymised data from another centre.
The optimised algorithm has a positive predictive value (PPV) of 99% for identifying cirrhosis in the derivation cohort, with a sensitivity of 86% (95% CI 82% to 90%) and a specificity of 98% (95% CI 96% to 100%). The sensitivity for detecting advanced stage cirrhosis is 80% (95% CI 75% to 87%) and specificity is 98% (95% CI 96% to 100%), with a PPV of 89%.
Our optimised algorithm, based on inpatient electronic health records, reliably identifies and stages cirrhosis in patients with HCC. This highlights the potential of routine health data in population studies to stratify patients with HCC according to liver disease severity.
肝细胞癌 (HCC) 的预后取决于肿瘤特征和肝脏疾病严重程度。本研究旨在验证使用住院电子病历从治疗和手术编码中确定肝脏疾病严重程度的方法。
回顾性观察性研究。
英国两个国家卫生服务(NHS)癌症中心。
2007 年至 2016 年间新诊断为 HCC 的 339 例患者。
我们使用住院电子病历开发了一种优化算法,以在 HCC 人群中识别肝硬化并确定肝脏疾病严重程度。该算法的诊断准确性在一个 NHS 信托的临床记录中进行了优化,并在另一个中心的匿名数据中进行了外部验证。
优化算法在推导队列中识别肝硬化的阳性预测值 (PPV) 为 99%,其敏感性为 86%(95%CI 82%至 90%),特异性为 98%(95%CI 96%至 100%)。检测晚期肝硬化的敏感性为 80%(95%CI 75%至 87%),特异性为 98%(95%CI 96%至 100%),PPV 为 89%。
我们基于住院电子病历的优化算法可靠地识别和分期 HCC 患者的肝硬化。这突出了常规健康数据在人群研究中根据肝脏疾病严重程度分层 HCC 患者的潜力。